On March 4, the Board of Pharmacy issued this temporary rule notice:
- OAR 855-115-0345 Pharmacist- Services: Prescribing – Protocol Compendium – Vaccines – Coronavirus 19 (Effective March 4, 2024)
- Coronavirus 19 protocol
This revised protocol permits pharmacists to provide an additional updated 2023-2024 COVID-19 vaccine dose to adults ages 65 years and older in alignment with the recent recommendation of the CDC (Centers for Disease Control) Advisory Committee on Immunization Practices’ (ACIP).
Also on Oregon, the Board of Pharmacy issued the following temporary rule notice:
- OAR 855-115-0345 Pharmacist- Services: Prescribing – Protocol Compendium Vaccines (Effective March 1, 2024)
- Standard Protocol for All Vaccines: Cover Page & Assessment and Treatment Care Pathway
- Standard Protocol for All Vaccines: Managing Adverse Reactions
- Cholera
- Coronavirus 19
- Haemophilus Influenzae type b
- Hepatitis A containing vaccines
- Hepatitis B containing vaccines
- Human Papillomavirus
- Influenza Inactivated Influenza Vaccines and Recombinant Influenza Vaccines 2023-2024
- Influenza Live Attenuated Influenza Vaccine 2023-2024
- Japanese Encephalitis
- Measles, Mumps & Rubella containing vaccines
- Meningococcal containing vaccines
- Pneumococcal
- Polio
- Rabies
- Respiratory Syncytial Virus
- Tetanus, Diphtheria containing vaccines
- Typhoid
- Varicella containing vaccines
- Yellow Fever
- Zoster
Also in Oregon, the Board of Pharmacy permanently repealed the following rules at the Special February 23, 2024, Board Meeting: OAR 855-019-0270, OAR 855-019-0280, OAR 855-019-0290 and OAR 855-025-0024 related to Pharmacist/COPT/PT Administration of Vaccines (Effective February 29, 2024)
Also in Oregon, the Board of Pharmacy permanently adopted the following rule at the February 2024 Board Meeting: OAR 855-115-0150 Pharmacist- Prohibited Practices (Effective March 1, 2024). Please note this rulemaking removes “Diagnosis” from the list of prohibited practices.
Finally in Oregon, the Prescription Drug Affordability Board posted the draft agenda for its next meeting on March 20. Please register in advance of the meeting.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.